EPILEPSY

Ned Sharpless, MD, the director of the National Cancer Institute, has been named to the position of acting FDA Commissioner. The announcement was made just a week after the current commissioner, Scott Gottlieb, MD, announced his plans to resign in early April.
The expert panelists share prominent take-home messages and discuss where they believe the field of epilepsy management will head in upcoming years.

SAP Partner Banner

About NeurologyLive's Epilepsy Clinical Focus page:

The NeurologyLive Epilepsy Clinical Focus page provides a hub for the latest clinical information pertaining to seizure disorders, with articles and videos closely covering the robust pipeline of new and emerging epilepsy therapies, as well as data from recent and ongoing clinical trials in the space. It serves as a well of information and news from relevant conferences and annual meetings hosted by neurological associations, and includes pivotal coverage right from the floor.

Among its offerings are videos featuring interviews with key opinion leaders and experts in epilepsy focused on best practices and key methods for recognizing and treating epilepsy symptoms, considering complex cases, applying novel therapies, addressing the issues and challenges of treating the disease, and much more.